comparemela.com

Latest Breaking News On - Adss for the company - Page 1 : comparemela.com

PHAXIAM Therapeutics announces effectiveness of voluntary delisting of American Depositary Shares from Nasdaq Stock Market

Lyon and Cambridge , March 11, 2024, at 07:00am CET – PHAXIAM Therapeutics , a biopharmaceutical company developing innovative treatments for severe and resistant bacterial infections, today.

France generalUnited statesUnited kingdomNew yorkEric soyerPharma bioEnregistrement universelArthur rouillCompany annual report on formAdss for the companySecurities exchangeCompany securitiesExchange commissionReceipt administrationAmerican depositary sharesNasdaq capital market

PHAXIAM Therapeutics announces effectiveness of voluntary delisting of American Depositary Shares from Nasdaq Stock Market - PHAXIAM Therapeutics (NASDAQ:PHXM)

Lyon (France) and Cambridge (MA, US), March 11, 2024, at 07:00am CET – PHAXIAM Therapeutics (Nasdaq & Euronext: PHXM), a biopharmaceutical company developing innovative treatments for severe and resistant

France generalUnited statesUnited kingdomNew yorkPharma bioEnregistrement universelReceipt administrationExchange commissionCompany annual report on formSecurities exchangeCompany securitiesAdss for the companyAmerican depositary sharesNasdaq capital marketSecurities exchange actExchange act

PHAXIAM Therapeutics announces intention to voluntary delist American Depositary Shares from The Nasdaq Capital Market

PHAXIAM Therapeutics announces intention to voluntary delist American Depositary Shares from The Nasdaq Capital MarketPHAXIAM remains listed on Eu.

France generalUnited kingdomUnited statesNew yorkArthur rouillPharma bioEnregistrement universelPherecydes pharmaEric soyerCompany annual report on formNasdaq stock market of the companyCompany adssCompany securitiesSecurities exchangeReceipt administrationExchange commission

Investegate | Company Announcement

Investegate announcements from PHAXIAM Therapeutics announces intention to voluntary delist American Depositary Shares from The Nasdaq Capital Market

United kingdomFrance generalUnited statesNew yorkEric soyerPherecydes pharmaPharma bioEnregistrement universelArthur rouillCompany securitiesCompany adssExchange commissionNasdaq stock market of the companySecurities exchangeAdss for the companyCompany annual report on form

Effectiveness of Voluntary Delisting of IDEX Biometrics ADSs from Nasdaq Capital Market

Effectiveness of Voluntary Delisting of IDEX Biometrics ADSs from Nasdaq Capital Market

New yorkUnited statesAdss for the companyCompany nasdaqSecurities exchangeExchange commissionReceipts divisionVoluntary delistingNasdaq capitalAmerican depositary sharesNasdaq capital marketSecurities exchange actExchange actNew york mellonDeposit agreementDepositary receipts division

vimarsana © 2020. All Rights Reserved.